Irem Dogan Turacli

8PUBLICATIONS
7CO-AUTHORS
BiomaterialsMolecular targetsAutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 15, 2026
Effects of Tranexamic Acid in Combination with Teicoplanin Against <i>Staphylococcus isolates</i>: Results from an In Vitro Study.

|Mar 28, 2026
Targeting Activated Pathways in Doxorubicin-Resistant TNBC Alters Signaling, Survival and EMT: A Double-Edged Sword.

Irem Dogan Turacli, Sahika Cingir Koker, Kubra Paspal Eroglu

|Jul 18, 2025
The effects of hsa-mir-26a-5p on cell proliferation, migration, and PI3K inhibitor sensitivity in metformin-resistant triple negative breast cancer cells.

Şahika Cingir Köker, Senem Noyan, Banu Yalçin

|Jan 25, 2025
The Platelet-Specific Gene Signature in the Immunoglobulin G4-Related Disease Transcriptome.

Ali Kemal Oguz, Cagdas Sahap Oygur, Bala Gur Dedeoglu

|Sep 12, 2022
Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis.

Funda Demirtas Korkmaz, Irem Dogan Turacli, Guldal Esendagli

|Jan 11, 2019
The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol.

Gulsah Albayrak, Funda Demirtas Korkmaz, Duygu Tozcu

Pageof 2

Frequent Collaborators

3 joint publications

Şahika Cingir Köker

1 joint publications

Funda Demirtas Korkmaz

1 joint publications

Guldal Esendagli

1 joint publications

Ali Kemal Oguz